Gilead Sciences, Inc. (NASDAQ:GILD) negotiated 8.45 million shares against it an average volume of 10.18 million shares. The stock concluded the recent trade at $79.57 with upbeat trend move of +0.85%. The company has total market value of 105.01B. The company has got a 52-week exceptional price of $117.70 and reached a 52-week lowest of the share price at $77.92. The daily trading range was observed between a day’s low price of $78.80 to a day’s high price of $79.98.
This Quarter Earnings Per Share Estimates:
According to FactSet data, Analysts estimated the EPS for This Quarter. These Analysts measured the Higher, Lower and Mean Estimated EPS for this stock. Mean Earnings Per Share (EPS) forecast is set at $2.88 by these analysts. Higher EPS estimate that can be reached in this quarter is determined at $3.11 and lower forecasted EPS is placed at $2.63. The mean EPS is calculated keeping in view the consensus of 22 Analysts. Coefficient Variance is noted at 4.84.
Next Quarter Earnings Per Share Estimates:
Different Analysts projected the EPS Estimate for Next Quarter. These Analysts measured the Maximum, Minimum and Mean EPS forecasts for this stock, according to FactSet. Mean EPS forecast of 22 analysts for Next Quarter is set at $2.81. Maximum EPS estimate that expected in next quarter is noted at $3.07 and minimum forecasted EPS is calculated at $2.55. Coefficient Variance is measured at 5.15.
Gilead Sciences Inc.’s (GILD) stock price showed weak performance of -0.25% in last seven days, switched down -7.21% in last thirty days and it fell -30.26% in last one year. It has 1328.48 million of outstanding shares and its shares float measured at 1323.66.
CorMedix Inc (NYSEMKT:CRMD) closed with gain of +24.82% to $1.76. Recent traded volume was 1.64 million shares versus to it an average volume of 333.56 thousand shares. The company market cap of 65.45M. The stock’s day range was recorded between a low of $1.42 and a high $1.83. The one year high of the company is $4.54 and the one year low is $1.15.
After the last closing session, the bid price was seen at 1.80. The bid price represents the higher price that a buyer or buyers are willing to pay for a security. The ask price was registered at 1.83. The ask price indicates the lower price that a seller or sellers are willing to receive for the security.
This Quarter Earnings Per Share Estimates:
According to FactSet data, Analysts estimated the EPS for This Quarter. These Analysts measured the Higher, Lower and Mean Estimated EPS for this stock. Mean Earnings Per Share (EPS) forecast is set at $-0.15 by these analysts. Higher EPS estimate that can be reached in this quarter is determined at $-0.14 and lower forecasted EPS is placed at $-0.18. The mean EPS is calculated keeping in view the consensus of 3 Analysts. Coefficient Variance is noted at -15.06.
Next Quarter Earnings Per Share Estimates:
Different Analysts projected the EPS Estimate for Next Quarter. These Analysts measured the Maximum, Minimum and Mean EPS forecasts for this stock, according to FactSet. Mean EPS forecast of 3 analysts for Next Quarter is set at $-0.17. Maximum EPS estimate that expected in next quarter is noted at $-0.15 and minimum forecasted EPS is calculated at $-0.21. Coefficient Variance is measured at -20.38.
CorMedix, Inc.’s (CRMD) price volatility for a month noted as 8.15% however its price volatility for a week documented as 11.82%. The corporation holds 36.01 million outstanding shares and its 35.46 million shares were floated in the market. The stock established a positive trend of 14.29% in last week and indicated rise of 4.76% in previous month.
This Quarter Earnings Per Share Estimates:
According to FactSet data, Analysts estimated the EPS for This Quarter. These Analysts measured the Higher, Lower and Mean Estimated EPS for this stock. Mean Earnings Per Share (EPS) forecast is set at $2.88 by these analysts. Higher EPS estimate that can be reached in this quarter is determined at $3.11 and lower forecasted EPS is placed at $2.63. The mean EPS is calculated keeping in view the consensus of 22 Analysts. Coefficient Variance is noted at 4.84.
Next Quarter Earnings Per Share Estimates:
Different Analysts projected the EPS Estimate for Next Quarter. These Analysts measured the Maximum, Minimum and Mean EPS forecasts for this stock, according to FactSet. Mean EPS forecast of 22 analysts for Next Quarter is set at $2.81. Maximum EPS estimate that expected in next quarter is noted at $3.07 and minimum forecasted EPS is calculated at $2.55. Coefficient Variance is measured at 5.15.
Gilead Sciences Inc.’s (GILD) stock price showed weak performance of -0.25% in last seven days, switched down -7.21% in last thirty days and it fell -30.26% in last one year. It has 1328.48 million of outstanding shares and its shares float measured at 1323.66.
CorMedix Inc (NYSEMKT:CRMD) closed with gain of +24.82% to $1.76. Recent traded volume was 1.64 million shares versus to it an average volume of 333.56 thousand shares. The company market cap of 65.45M. The stock’s day range was recorded between a low of $1.42 and a high $1.83. The one year high of the company is $4.54 and the one year low is $1.15.
After the last closing session, the bid price was seen at 1.80. The bid price represents the higher price that a buyer or buyers are willing to pay for a security. The ask price was registered at 1.83. The ask price indicates the lower price that a seller or sellers are willing to receive for the security.
This Quarter Earnings Per Share Estimates:
According to FactSet data, Analysts estimated the EPS for This Quarter. These Analysts measured the Higher, Lower and Mean Estimated EPS for this stock. Mean Earnings Per Share (EPS) forecast is set at $-0.15 by these analysts. Higher EPS estimate that can be reached in this quarter is determined at $-0.14 and lower forecasted EPS is placed at $-0.18. The mean EPS is calculated keeping in view the consensus of 3 Analysts. Coefficient Variance is noted at -15.06.
Next Quarter Earnings Per Share Estimates:
Different Analysts projected the EPS Estimate for Next Quarter. These Analysts measured the Maximum, Minimum and Mean EPS forecasts for this stock, according to FactSet. Mean EPS forecast of 3 analysts for Next Quarter is set at $-0.17. Maximum EPS estimate that expected in next quarter is noted at $-0.15 and minimum forecasted EPS is calculated at $-0.21. Coefficient Variance is measured at -20.38.
CorMedix, Inc.’s (CRMD) price volatility for a month noted as 8.15% however its price volatility for a week documented as 11.82%. The corporation holds 36.01 million outstanding shares and its 35.46 million shares were floated in the market. The stock established a positive trend of 14.29% in last week and indicated rise of 4.76% in previous month.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.